Prevalence of Serum Vitamin D Deficiency and Insufficiency in Cancer

Fat-soluble Vitamin D plays a critical role in maintaining bone health and regulating the absorption of calcium and phosphorus. Interest in Vitamin D’s potential role in treating and counteracting malignant development has grown recently. According to epidemiological research, higher Vitamin D levels may be associated with a lower risk of developing certain cancers, such as colorectal, breast, and prostate cancer. The current investigation aims to determine the correlation between the prevalence of Vitamin D deficiency in the serum and the development of cancer. Studies conducted in research centers have also suggested that Vitamin D may possess anti-malignant growth characteristics, such as the ability to trigger apoptosis (a modified form of cell death) and inhibit the proliferation of malignant development cells. However, the results of the first clinical trials investigating the use of Vitamin D as a preventative or malignant growth therapy have been mixed, and the optimal dosage and duration of Vitamin D supplementation for illness prevention or treatment remain unclear. Additional research is anticipated to identify subpopulations that may benefit most from Vitamin D supplementation and to clarify the potential benefits and risks of this medication for malignant growth anticipation. Nevertheless, ensuring adequate Vitamin D intake through supplementation or sun exposure may be a key strategy for reducing the risk of cancerous development and improving overall health.